Bruce C. Cozadd
2014
In 2014, Bruce C. Cozadd earned a total compensation of $11.6M as Chairman and CEO at Jazz Pharmaceuticals, a 40% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,020,900 |
|---|---|
| Option Awards | $4,194,452 |
| Salary | $830,000 |
| Stock Awards | $5,498,457 |
| Other | $11,692 |
| Total | $11,555,501 |
Cozadd received $5.5M in stock awards, accounting for 48% of the total pay in 2014.
Cozadd also received $1M in non-equity incentive plan, $4.2M in option awards, $830K in salary and $11.7K in other compensation.
Rankings
In 2014, Bruce C. Cozadd's compensation ranked 397th out of 13,032 executives tracked by ExecPay. In other words, Cozadd earned more than 97.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 397 out of 13,032 | 97th |
Division Manufacturing | 143 out of 4,965 | 97th |
Major group Chemicals And Allied Products | 46 out of 1,690 | 97th |
Industry group Drugs | 36 out of 1,369 | 97th |
Industry Pharmaceutical Preparations | 34 out of 1,042 | 97th |
Source: SEC filing on June 20, 2017.
Cozadd's colleagues
We found five more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2014.
2014
Russell Cox
Jazz Pharmaceuticals
Chief Operating Officer
2014
Suzanne Hooper
Jazz Pharmaceuticals
Executive Vice President and GC
2014
Matthew Young
Jazz Pharmaceuticals
Chief Financial Officer
2014
Michael Miller
Jazz Pharmaceuticals
Senior Vice President, U.S. Commercial
2014
Kathryn Falberg
Jazz Pharmaceuticals
Chief Financial Officer
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019